Sort
21,453 grants matching “tuberculosis”
Regulators of IFN-gamma responses during Mycobacterium tuberculosis infection
$523,984Andrew Olive · Michigan State University · R01 · FY2025 · AI
Regulators of IFN-gamma responses during Mycobacterium tuberculosis infection
$523,984Andrew Olive · Michigan State University · R01 · FY2022 · AI
Defining the impact of pre-existing memory T cells in human immunity
$523,802Laura Su · University Of Pennsylvania · R01 · FY2018 · AI
Defining the impact of pre-existing memory T cells in human immunity
$523,802Laura Su · University Of Pennsylvania · R01 · FY2019 · AI
HIV/TB in Uganda: Punctuated Antiretroviral Therapy
$523,770Christopher C. Whalen · Case Western Reserve University · R01 · FY2007 · AI
Training
$523,745Patricia A Totten · Path · U54 · FY2010 · EB
Multi-level and Intersectional Stigma and other Social Determinant Effects on TB Case Detection, Care, and Treatment Outcomes: The MISSED TB Outcomes Study
$523,707Andrew Medina-Marino · Desmond Tutu Hiv Foundation · R01 · FY2023 · AI
Coping With HIV/AIDS in Tanzania
$523,681Kathryn Whetten · Duke University · R01 · FY2009 · MH
Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence
$523,560Philip J Goulder · University Of Oxford · U01 · FY2025 · AI
POPULATION BASED INVESTIGATIONS OF TUBERCULOSIS
$523,512Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2003 · AI
ArmR: a novel drug target and mediator of antibiotic resistance
$523,464David S Weiss · Emory University · R33 · FY2014 · AI
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 2/2)
$523,405Gabriel Chamie · University Of California, San Francisco · U01 · FY2020 · AA
Optimizing the impact of Xpert MTB/RIF on treatment outcomes of drug resistant TB
$523,383Annelies Van Rie · Univ Of North Carolina Chapel Hill · R01 · FY2013 · AI
ArmR: a novel drug target and mediator of antibiotic resistance
$523,329David S Weiss · Emory University · R33 · FY2015 · AI
Mechanisms of T Cell Memory Quiescence
$523,322Surojit Sarkar · Seattle Children'S Hospital · R01 · FY2019 · AI
Mechanisms of T Cell Memory Quiescence
$523,322Surojit Sarkar · Seattle Children'S Hospital · R01 · FY2020 · AI
Drug Development for MDR-M tuberculosis
$523,169James D Dick · Johns Hopkins University · U01 · FY2006 · AI
Administrative Core
$523,069Paul Edward Farmer · Brigham And Women'S Hospital · U19 · FY2009 · AI
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
$522,913Shruti H Mehta · Johns Hopkins University · R01 · FY2015 · DA
The Role of Alcohol Use in Incident TB Infection and Active TB Disease Among Persons Living with HIV
$522,909Judith Alissa Hahn · Boston Medical Center · P01 · FY2021 · AA
Cell Migration in Tuberculosis Infection
$522,759Yeshiva University · R01 · FY2003 · HL
Project 1: Listeria metabolites and innate immunity
$522,624Daniel A Portnoy · University Of California Berkeley · P01 · FY2024 · AI
Project 1: Listeria metabolites and innate immunity
$522,624Daniel A Portnoy · University Of California Berkeley · P01 · FY2023 · AI
METABOLIC REPROGRAMMING OF T CELL ENERGY METABOLISM IN TUBERCULOSIS AND HIV
$522,518Adrie Jc Steyn · University Of Alabama At Birmingham · R61 · FY2018 · AI
Discovery of inhibitors that target the Mtb ClpP1P2 protease
$522,353Eric Joseph Rubin · Global Alliance For Tb Drug Development · U19 · FY2020 · AI